Aquestive Therapeutics (AQST) Assets Average (2018 - 2025)
Historic Assets Average for Aquestive Therapeutics (AQST) over the last 8 years, with Q3 2025 value amounting to $128.6 million.
- Aquestive Therapeutics' Assets Average rose 1304.87% to $128.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $128.6 million, marking a year-over-year increase of 1304.87%. This contributed to the annual value of $79.4 million for FY2024, which is 3874.12% up from last year.
- According to the latest figures from Q3 2025, Aquestive Therapeutics' Assets Average is $128.6 million, which was up 1304.87% from $98.0 million recorded in Q2 2025.
- In the past 5 years, Aquestive Therapeutics' Assets Average ranged from a high of $128.6 million in Q3 2025 and a low of $54.1 million during Q3 2022
- Its 5-year average for Assets Average is $77.9 million, with a median of $63.6 million in 2021.
- As far as peak fluctuations go, Aquestive Therapeutics' Assets Average soared by 10893.65% in 2024, and later plummeted by 2071.64% in 2025.
- Aquestive Therapeutics' Assets Average (Quarter) stood at $63.6 million in 2021, then fell by 14.43% to $54.5 million in 2022, then rose by 7.3% to $58.4 million in 2023, then skyrocketed by 80.88% to $105.7 million in 2024, then grew by 21.7% to $128.6 million in 2025.
- Its Assets Average stands at $128.6 million for Q3 2025, versus $98.0 million for Q2 2025 and $101.8 million for Q1 2025.